During the past decade, Mid America Diabetes Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid America Diabetes Associates" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mid America Diabetes Associates" are "Type 1 Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type II" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "Mid America Diabetes Associates" in a lesser frequency.

Most popular intervention types in "Mid America Diabetes Associates" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insulin aspart" (2 trials), "Insulin glargine" (2 trials), "Insulin glulisine" (2 trials), "Insulin lispro" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mid America Diabetes Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Mid America Diabetes Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mid America Diabetes Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mid America Diabetes Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".